Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Inflammation is likely a key contributor to the pathogenesis of Parkinson's disease (PD), a progressively debilitating neurodegenerative disease that is accompanied by a pathological accumulation of the α-synuclein protein in a staged manner through the brain. What leads to the accumulation of α-synuclein in PD and how this relates to inflammatory pathways, however, is not entirely clear. Toll-like receptor (TLR) signaling is a major pathway mediating inflammation and, in particular, TLR2 is increasingly being implicated in PD. We have, therefore, examined the expression of TLR2 in postmortem brain tissue from PD patients and matched controls. We confirm that TLR2 is increased in PD brain, and find that levels of TLR2 correlate with the accumulation of pathological α-synuclein. TLR2 was expressed on neurons as well as microglia; however, the neuronal rather than glial expression of TLR2 was significantly increased in PD brain in accordance with disease staging, and TLR2 was strongly localized to α-synuclein positive Lewy bodies. In cell culture, activation of neuronal TLR2 induced an inflammatory response, including the secretion of inflammatory cytokines and microglial-activating chemokines, as well as the production of reactive oxygen species. Moreover, activation of neuronal TLR2 increased levels of endogenous α-synuclein protein, which was in turn associated with increased levels of the autophagy/lysosomal pathway marker p62. Finally, promoting autophagy with rapamycin or pharmacological inhibition of the TLR2 signaling pathway prevented the TLR2-mediated increase in α-synuclein in neuronal cell cultures. These results implicate neuronal TLR2 expression in human PD pathogenesis. In particular, the increased expression of TLR2 on neurons may provide new insight into disease pathogenesis and/or options for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The activation of neuronal TLR2 in the brains of patients with Parkinson's disease results in increased proinflammatory cytokine (TNF) levels and recruitment of microglia to amplify neuroinflammation as well as increased expression of asynuclein.158”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [158]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TLR2 also plays a role in neurons in response to α-synuclein in addition to microglia19,57,58.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [57]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has been suggested that TLR2 expression is upregulated in PD postmortem human brains.291,292”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [292]
The cited source says what the claim attributes to it.
In the citing paper
“TLR2 also plays a role in neurons in response to α-synuclein in addition to microglia19,57,58.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Gene expression was quantified using the comparative Ct method [24] with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the housekeeping gene.”
MethodStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“Pathologically, PD is defined by the selective degeneration of dopamine-producing neurons in the substantia nigra pars compacta with concomitant accumulation of α-synuclein-rich proteinaceous neuronal inclusions, termed Lewy bodies, which propagate in a predicative or staged fashion through multiple brain regions [5,…”
BackgroundSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 1×
“TLRs mediate the recognition of exogenous conserved structures known as pathogen-associated molecular patterns (PAMPs) [18], and endogenous damage-associated molecular patterns (DAMPs) [33].”
BackgroundMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · cited 1×
“1 3 cytokines are increased in the brain, CSF and serum of PD patients [7, 17, 31] and activated microglia are prevalent in the most pathologically effected areas of the brains of patients with PD [26].”
Backgroundα-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins
Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R. L., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.10 · Cited by 1,329 · cited 1×
“4b), which specifically activates TLR2/ TLR1 dimers [40].”
BackgroundZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 2×
“Recent reports have suggested that α-synuclein is a DAMP, capable of modulating inflammatory cytokine production in microglia [1, 3, 21, 39, 47].”
BackgroundPAMP s and DAMP s: signal 0s that spur autophagy and immunity
Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01146.x · Cited by 1,221 · cited 1×
“PAMPS derive from a range of microorganisms absent from the host such as viruses, bacteria, fungi and parasites, while DAMPs are released following cellular stress and from damaged tissues [41].”
BackgroundInfluentialMogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977 · cited 1×
“It is characterized by motor symptoms such as tremor, rigidity, bradykinesia and gait imbalance, as well as non-motor symptoms such as executive dysfunction deficits, sleep disturbances and depression [13].”
BackgroundDAMPening Inflammation by Modulating TLR Signalling
Piccinini, A. M., & Midwood, K. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/672395 · Cited by 973 · cited 1×
“TLRs mediate the recognition of exogenous conserved structures known as pathogen-associated molecular patterns (PAMPs) [18], and endogenous damage-associated molecular patterns (DAMPs) [33].”
BackgroundKim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · cited 3×
“Both oligomeric [19] and fibrilar [15] forms of α-synuclein have been shown to activate microglial TLR2 in tissue culture experiments.”
BackgroundMogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Changes in cytokines and neurotrophins in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6301-6_19 · Cited by 510
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
Murphy, K. E., Gysbers, A. M., Abbott, S. K., Tayebi, N., Kim, W. S., Sidransky, E., Cooper, A., Garner, B., & Halliday, G. M. (2014) · Brain · doi:10.1093/brain/awt367 · Cited by 475 · cited 6×
“1e shows group comparisons, also shown previously [29]) and TLR2 levels (Fig.”
BackgroundMethodSelf-citationSynuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474 · cited 2×
“Recent reports have suggested that α-synuclein is a DAMP, capable of modulating inflammatory cytokine production in microglia [1, 3, 21, 39, 47].”
BackgroundRapamycin Protects against Neuron Death in In Vitro and In Vivo Models of Parkinson's Disease
Malagelada, C., Jin, Z. H., Jackson-Lewis, V., Przedborski, S., & Greene, L. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3944-09.2010 · Cited by 462 · cited 1×
“Interestingly, activation of autophagy with rapamycin was able to ameliorate the TLR2-mediated increase in α-synuclein, suggesting that activating autophagy can help clear α-synuclein protein, as has been seen before in animal studies [2, 23, 25, 32].”
ResultMicroscopic analysis of polymerization dynamics with individual actin filaments
Fujiwara, I., Takahashi, S., Tadakuma, H., Funatsu, T., & Ishiwata, S. (2002) · Nature Cell Biology · doi:10.1038/ncb841 · Cited by 420
The progression of pathology in longitudinally followed patients with Parkinson’s disease
Halliday, G., Hely, M., Reid, W., & Morris, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0344-8 · Cited by 414 · cited 1×
“Pathologically, PD is defined by the selective degeneration of dopamine-producing neurons in the substantia nigra pars compacta with concomitant accumulation of α-synuclein-rich proteinaceous neuronal inclusions, termed Lewy bodies, which propagate in a predicative or staged fashion through multiple brain regions [5,…”
BackgroundSelf-citationThe Role of Innate and Adaptive Immunity in Parkinson's Disease
Kannarkat, G. T., Boss, J. M., & Tansey, M. G. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130250 · Cited by 324 · cited 1×
“1 3 cytokines are increased in the brain, CSF and serum of PD patients [7, 17, 31] and activated microglia are prevalent in the most pathologically effected areas of the brains of patients with PD [26].”
BackgroundThe Role of the Selective Adaptor p62 and Ubiquitin-Like Proteins in Autophagy
Lippai, M., & Lőw, P. (2014) · BioMed Research International · doi:10.1155/2014/832704 · Cited by 322 · cited 1×
“We did not find differences in the autophagy markers beclin1 or LC3 following TLR2 activation; however, we did find that TLR2 activation increased the levels of p62/SQSTIM1, a receptor for selective autophagy of target proteins potentially including α-synuclein [22, 42, 45], that is known to increase when autophagy/ly…”
BackgroundAn inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309 · cited 1×
“1 3 cytokines are increased in the brain, CSF and serum of PD patients [7, 17, 31] and activated microglia are prevalent in the most pathologically effected areas of the brains of patients with PD [26].”
BackgroundSelf-citationContributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 306 · cited 1×
“1 3 cytokines are increased in the brain, CSF and serum of PD patients [7, 17, 31] and activated microglia are prevalent in the most pathologically effected areas of the brains of patients with PD [26].”
BackgroundDaniele, S. G., Béraud, D., Davenport, C., Cheng, K., Yin, H., & Maguire-Zeiss, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.2005965 · Cited by 303 · cited 1×
“The exact contribution of different α-synuclein conformations to TLR activation is currently unclear; however, it has been demonstrated that α-synuclein can at least activate the TLR2 receptor on microglia and promote inflammatory cytokine production [9, 15, 19].”
BackgroundBrun, P., Giron, M. C., Qesari, M., Porzionato, A., Caputi, V., Zoppellaro, C., Banzato, S., Grillo, A. R., Spagnol, L., De Caro, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.047 · Cited by 300 · cited 1×
“Increased TLR2 expression on enteric and hypothalamic neurons was recently reported in the context of obesity and peripheral changes [6, 37], further confirming the potential of this innate immune pathway in neuronal cells to respond to regionally relevant disease signals.”
BackgroundAlpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship
Xilouri, M., Brekk, O. R., & Stefanis, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8341-2 · Cited by 299 · cited 2×
“This suggested a potential defect in the turnover of α-synuclein protein, which is not clearly understood but involves both proteosomal and lysosmal degradation [46].”
BackgroundRapamycin protects against rotenone-induced apoptosis through autophagy induction
Pan, T., Rawal, P., Wu, Y., Xie, W., Jankovic, J., & Le, W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.014 · Cited by 273 · cited 1×
“Interestingly, activation of autophagy with rapamycin was able to ameliorate the TLR2-mediated increase in α-synuclein, suggesting that activating autophagy can help clear α-synuclein protein, as has been seen before in animal studies [2, 23, 25, 32].”
ResultLee, E.-J., Woo, M.-S., Moon, P.-G., Baek, M.-C., Choi, I.-Y., Kim, W.-K., Junn, E., & Kim, H.-S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903480 · Cited by 267 · cited 2×
“Recent reports have suggested that α-synuclein is a DAMP, capable of modulating inflammatory cytokine production in microglia [1, 3, 21, 39, 47].”
BackgroundDoorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D., Lucassen, P. J., & van Dam, A.-M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0090-1 · Cited by 254 · cited 1×
“Indeed, recent evidence suggests an upregulation of TLR2 on microglia in the substantia nigra of PD brain [11].”
BackgroundInflammation is genetically implicated in Parkinson’s disease
Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222 · cited 2×
“A number of genes that can either directly cause PD or contribute to its risk are implicated in inflammatory pathways [10, 12].”
BackgroundSelf-citationα-Synuclein Alters Toll-Like Receptor Expression
Béraud, D., Twomey, M., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T. R., & Maguire-Zeiss, K. A. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00080 · Cited by 198 · cited 4×
“TLRs mediate the recognition of exogenous conserved structures known as pathogen-associated molecular patterns (PAMPs) [18], and endogenous damage-associated molecular patterns (DAMPs) [33].”
BackgroundInfluentialAlpha-synuclein release by neurons activates the inflammatory response in a microglial cell line
Alvarez-Erviti, L., Couch, Y., Richardson, J., Cooper, J. M., & Wood, M. J. A. (2011) · Neuroscience Research · doi:10.1016/j.neures.2010.12.020 · Cited by 193 · cited 2×
“Recent reports have suggested that α-synuclein is a DAMP, capable of modulating inflammatory cytokine production in microglia [1, 3, 21, 39, 47].”
BackgroundAmyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
Gustot, A., Gallea, J. I., Sarroukh, R., Celej, M. S., Ruysschaert, J.-M., & Raussens, V. (2015) · Biochemical Journal · doi:10.1042/bj20150617 · Cited by 184 · cited 2×
“Both oligomeric [19] and fibrilar [15] forms of α-synuclein have been shown to activate microglial TLR2 in tissue culture experiments.”
BackgroundBéraud, D., Hathaway, H. A., Trecki, J., Chasovskikh, S., Johnson, D. A., Johnson, J. A., Federoff, H. J., Shimoji, M., Mhyre, T. R., & Maguire-Zeiss, K. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9401-0 · Cited by 172 · cited 2×
“Recent reports have suggested that α-synuclein is a DAMP, capable of modulating inflammatory cytokine production in microglia [1, 3, 21, 39, 47].”
BackgroundThe role of inflammation in sporadic and familial Parkinson’s disease
Deleidi, M., & Gasser, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1352-y · Cited by 167 · cited 2×
“A number of genes that can either directly cause PD or contribute to its risk are implicated in inflammatory pathways [10, 12].”
BackgroundqPrimerDepot: a primer database for quantitative real time PCR
Cui, W., Taub, D. D., & Gardner, K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl767 · Cited by 158 · cited 1×
“All primer sequences were obtained from qPrimer depot [8] and synthesized by Sigma.”
MethodTLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors
van Bergenhenegouwen, J., Plantinga, T. S., Joosten, L. A. B., Netea, M. G., Folkerts, G., Kraneveld, A. D., Garssen, J., & Vos, A. P. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113003 · Cited by 141 · cited 1×
“TLR2 is considered the most promiscuous of TLR receptors, being that it is able to bind a diverse selection of agonists including bacterial lipopeptides, yeast cell components and mycoplasma [43].”
BackgroundAntagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy
Kim, C., Rockenstein, E., Spencer, B., Kim, H.-K., Adame, A., Trejo, M., Stafa, K., Lee, H.-J., Lee, S.-J., & Masliah, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.044 · Cited by 135 · cited 2×
“, also extend their studies to animal models and show that α-synuclein-mediated neurodegeneration is attenuated by either knockout or knockdown of TLR2 in rodent PD models [20].”
BackgroundResultTherapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
Liu, K., Shi, N., Sun, Y., Zhang, T., & Sun, X. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0909-8 · Cited by 118 · cited 1×
“Interestingly, activation of autophagy with rapamycin was able to ameliorate the TLR2-mediated increase in α-synuclein, suggesting that activating autophagy can help clear α-synuclein protein, as has been seen before in animal studies [2, 23, 25, 32].”
Resultp62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
Watanabe, Y., Tatebe, H., Taguchi, K., Endo, Y., Tokuda, T., Mizuno, T., Nakagawa, M., & Tanaka, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052868 · Cited by 99 · cited 1×
“We did not find differences in the autophagy markers beclin1 or LC3 following TLR2 activation; however, we did find that TLR2 activation increased the levels of p62/SQSTIM1, a receptor for selective autophagy of target proteins potentially including α-synuclein [22, 42, 45], that is known to increase when autophagy/ly…”
BackgroundRoodveldt, C., Labrador-Garrido, A., Gonzalez-Rey, E., Lachaud, C. C., Guilliams, T., Fernandez-Montesinos, R., Benitez-Rondan, A., Robledo, G., Hmadcha, A., Delgado, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079160 · Cited by 98
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Wales, P., Pinho, R., Lázaro, D. F., & Outeiro, T. F. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130216 · Cited by 86 · cited 1×
“As well as forming insoluble Lewy body aggregates in PD brain, α-synuclein also forms monomers, oligomers, fibrils and other conformations [44].”
BackgroundSasaki, A., Arawaka, S., Sato, H., & Kato, T. (2015) · Scientific Reports · doi:10.1038/srep14211 · Cited by 80 · cited 1×
“1% glutaraldehyde prior to blocking as described [36].”
Bai, X., Wey, M. C.-Y., Fernandez, E., Hart, M. J., Gelfond, J., Bokov, A. F., Rani, S., & Strong, R. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.28743 · Cited by 61 · cited 1×
“Interestingly, activation of autophagy with rapamycin was able to ameliorate the TLR2-mediated increase in α-synuclein, suggesting that activating autophagy can help clear α-synuclein protein, as has been seen before in animal studies [2, 23, 25, 32].”
Resultp 62 Deficiency Enhances α‐Synuclein Pathology in Mice
Tanji, K., Odagiri, S., Miki, Y., Maruyama, A., Nikaido, Y., Mimura, J., Mori, F., Warabi, E., Yanagawa, T., Ueno, S., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12214 · Cited by 49
Hypothalamic neuronal toll-like receptor 2 protects against age-induced obesity
Shechter, R., London, A., Kuperman, Y., Ronen, A., Rolls, A., Chen, A., & Schwartz, M. (2013) · Scientific Reports · doi:10.1038/srep01254 · Cited by 41 · cited 1×
“Increased TLR2 expression on enteric and hypothalamic neurons was recently reported in the context of obesity and peripheral changes [6, 37], further confirming the potential of this innate immune pathway in neuronal cells to respond to regionally relevant disease signals.”
Background
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“TLR2 activation further enhances the aggregation of α-synuclein by regulating autophagy.(292) In line with these results, blocking the interaction between TLR2 and MyD88 can reduce the activation of glial cells, decrease α-synuclein spreading, and protect dopaminergic neurons.”
BackgroundResultAutophagy: The spotlight for cellular stress responses
Ravanan, P., Srikumar, I. F., & Talwar, P. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.08.029 · Cited by 580
Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
Choi, I., Zhang, Y., Seegobin, S. P., Pruvost, M., Wang, Q., Purtell, K., Zhang, B., & Yue, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-15119-w · Cited by 608
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487
Autophagy in neurodegenerative diseases: pathogenesis and therapy
Guo, F., Liu, X., Cai, H., & Le, W. (2018) · Brain Pathology · doi:10.1111/bpa.12545 · Cited by 444
“Notably, excess autophagosomes and autolysosomes are closely associated with p62/SQSTM1 positive inclusions, suggesting an impaired cargo digestion in lysosome (112).”
BackgroundInfluential
Metadata
- Authors
- Dzamko, N., Gysbers, A., Perera, G., Bahar, A., Shankar, A., Gao, J., Fu, Y., & Halliday, G. M.
- Affiliations
- UNSW Sydney (AU)
- Neuroscience Research Australia (AU)
- Corresponding author
- Dzamko, Nicolas
- Halliday, Glenda M.
- Venue
- Acta Neuropathologica
- Published
- 2016-11-25
- Volume
- 133
- Issue
- 2
- Pages
- 303-319
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC5250664
- OpenAlex
- W2554874133
- Semantic Scholar
- 6d5ed92f5026eb13731b365c8793acdf5588d2a7
- Cited by
- 273
- References
- 49
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 34 · 2023: 35 · 2022: 42 · 2021: 40 · 2020: 26 · 2019: 23 · 2018: 24 · 2017: 12
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council
- Parkinson's NSW
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, TLR2, alpha-synuclein, neuroinflammation, Lewy bodies, microglia, autophagy, p62, reactive oxygen species, inflammatory cytokines, chemokines, disease staging, rapamycin, TLR2 signaling
- MeSH terms
- Aged, Aged, 80 and over, Brain, Female, Humans, Inflammation, Male, Middle Aged, Parkinson Disease, Toll-Like Receptor 2, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.